文献速递泌尿生殖介入US

顺行超声造影肾造瘘造影评估输尿管通畅性的可行性

Feasibility of Antegrade Contrast-enhanced US Nephrostograms to Evaluate Ureteral Patency.
PubMed 文献 · Radiology · 2016-10-19

这项前瞻性盲法先导研究纳入了9例经皮肾镜取石术后患者,在术后第1天经肾造瘘管注入1.5 mL Optison行超声造影肾造瘘造影,并与透视下肾造瘘造影对照。10次检查中超声造影显示8次通畅、2次梗阻,与透视结果完全一致(95%CI 69.2%–100%),无相关并发症。作者认为该技术操作简单,但完全一致的结果尚不足以确立诊断准确性,需进一步更大规模研究。

要点

  • 经肾造瘘管注入1.5 mL Optison行超声造影,以膀胱内出现造影剂定义输尿管通畅。
  • 10次检查中超声造影与透视下肾造瘘造影结果完全一致,95%CI为69.2%–100%。
  • 作者指出该一致性尚不足以确立诊断准确性,需进一步更大规模研究。

核心结论

  • 超声造影肾造瘘造影操作简单,能显示输尿管通畅与梗阻,与透视结果完全一致,但尚不足以确立诊断准确性,需进一步更大规模研究。

研究设计与样本

  • 符合HIPAA、经机构审查委员会批准的前瞻性盲法先导研究,共9例患者(4女5男)行10次检查,术后第1天经肾造瘘管注入1.5 mL Optison行超声造影,并与透视下肾造瘘造影对照。

关键影像表现/征象

  • 超声造影以膀胱内出现造影剂定义顺行输尿管通畅,10次检查中8次显示通畅、2次显示梗阻。

诊断标准与关键数值

  • 以膀胱内出现造影剂定义顺行输尿管通畅,10次检查中超声造影显示8次通畅、2次梗阻。
  • 超声造影与透视下肾造瘘造影结果完全一致,95%CI为69.2%–100%。

临床应用与阅片要点

  • 作者认为若后续更大规模研究证实这些初步结果,超声造影可能提供比透视更安全、更便捷的输尿管通畅性评估方式。

局限性

  • 作者指出10次检查中与透视结果的完全一致尚不足以确立该技术的诊断准确性,需进一步更大规模研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To demonstrate the feasibility of contrast material-enhanced ulrasonographic (US) nephrostograms to assess ureteral patency after percutaneous nephrolithotomy (PCNL) in this proof-of-concept study. Materials and Methods For this HIPAA-compliant, institutional review board-approved prospective blinded pilot study, patients undergoing PCNL provided consent to undergo contrast-enhanced US and fluoroscopic nephrostograms on postoperative day 1. For contrast-enhanced US, 1.5 mL of Optison (GE Healthcare, Oslo, Norway) microbubble contrast agent solution (perflutren protein-type A microspheres) was injected via the nephrostomy tube. Unobstructed antegrade ureteral flow was defined by the presence of contrast material in the bladder. Contrast-enhanced US results were compared against those of fluoroscopic nephrostograms for concordance. Results Ten studies were performed in nine patients (four women, five men). Contrast-enhanced US demonstrated ureteral patency in eight studies and obstruction in two. One patient underwent two studies, one showing obstruction and the second showing patency. Concordance between US and fluoroscopic assessments of ureteral patency was evaluated by using a Clopper-Pearson exact binomial test. These results were perfectly concordant with fluoroscopic nephrostogram results, with a 95% confidence interval of 69.2% and 100%. No complications or adverse events related to contrast-enhanced US occurred. Conclusion Contrast-enhanced US nephrostograms are simple to perform and are capable of demonstrating both patency and obstruction of the ureter. The perfect concordance with fluoroscopic results across 10 studies demonstrated here is not sufficient to establish diagnostic accuracy of this technique, but motivates further, larger scale investigation. If subsequent larger studies confirm these preliminary results, contrast-enhanced US may provide a safer, more convenient way to evaluate ureteral patency than fluoroscopy. © RSNA, 2016 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Chi T, Usawachintachit M, Mongan J, et al. Feasibility of Antegrade Contrast-enhanced US Nephrostograms to Evaluate Ureteral Patency. Radiology. 2016. PMID: 28234551. doi:10.1148/radiol.2016160959

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。